Top

BMC Geriatrics

Published in:

Open Access 01-12-2023 | Prostate Cancer | Research

Interaction between drinking and dietary inflammatory index affects prostate specific antigen: a cross-sectional study

Authors: Xiangtao Weng, Wenyue Tan, Baian Wei, Shijian Yang, Chiming Gu, Shusheng Wang

Published in: BMC Geriatrics | Issue 1/2023

Abstract

Background

Numerous studies have shown that the dietary inflammatory index (DII) is associated with adverse health effects. However, the relationship between DII and prostate cancer (PCa) remains controversial. Although alcohol is included in DII as a dietary factor, the various adverse health effects of alcohol consumption are not only related to inflammation. On the other hand, it has been a long-standing debate whether alcohol consumption is linked to the risk of PCa. Therefore, to clarify whether drinking affects the relationship between DII and PCa, we evaluated the correlation between DII and prostate-specific antigen (PSA) based on the National Health and Nutrition Examination Survey (NHANES) database.

Methods

We used data from the NHANES spanning from 2005 to 2010 to analyze the relationship between PCa and DII. Out of the 31,034 NHANES participants, we enrolled 4,120 individuals in our study, utilizing dietary intake data from a twenty-four-hour period to determine DII scores. Demographic data, physical and laboratory test results were collected to compare between low PSA and high PSA groups, and to calculate the odds ratio between both groups, we employed a logistic regression analysis.

Results

In this cross-sectional investigation of PCa, drinkers and non-drinkers had different relationships between DII and PSA levels (OR: 1.2, 95% Cl: 1-1.44 vs. OR: 0.98, 95% Cl: 0.9–1.07), and DII and abstaining from alcohol were effective in reducing the incidence of PSA (p-value for significant interaction = 0.037).

Conclusion

The results of our study suggest that drinking may influence the relationship between DII and PSA levels. DII is likely to be a reliable indicator for estimating PSA levels among non-drinkers, who may limit their intake of pro-inflammatory ingredients to lower the incidence and death of PCa.

Available only for authorised users

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. Cancer J Clin. 2015;65:87–108. https://doi.org/10.3322/caac.21262.CrossRef

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.CrossRef

Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77:38–52. https://doi.org/10.1016/j.eururo.2019.08.005.CrossRefPubMed

Minihane AM, Vinoy S, Russell WR, Baka A, Roche HM, Tuohy KM, Teeling JL, Blaak EE, Fenech M, Vauzour D, et al. Low-grade inflammation, diet composition and health: current research evidence and its translation. Br J Nutr. 2015;114:999–1012. https://doi.org/10.1017/S0007114515002093.CrossRefPubMedPubMedCentral

Fu BC, Tabung FK, Pernar CH, Wang W, Gonzalez-Feliciano AG, Chowdhury-Paulino IM, Clinton SK, Folefac E, Song M, Kibel AS, et al. Insulinemic and inflammatory dietary patterns and risk of prostate Cancer. Eur Urol. 2021;79:405–12. https://doi.org/10.1016/j.eururo.2020.12.030.CrossRefPubMedPubMedCentral

Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17:1689–96. https://doi.org/10.1017/S1368980013002115.CrossRefPubMed

Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017;141:2215–27. https://doi.org/10.1002/ijc.30922.CrossRefPubMedPubMedCentral

Marx W, Veronese N, Kelly JT, Smith L, Hockey M, Collins S, Trakman GL, Hoare E, Teasdale SB, Wade A, et al. The Dietary Inflammatory Index and Human Health: an Umbrella Review of Meta-Analyses of Observational Studies. Adv Nutr. 2021;12:1681–90. https://doi.org/10.1093/advances/nmab037.CrossRefPubMedPubMedCentral

GBD 2016 Alcohol Collaborators. Lancet. 2018;392:1015–35. https://doi.org/10.1016/S0140-6736(18)31310-2. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.

10.

Rumgay H, Murphy N, Ferrari P, Soerjomataram I. Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients. 2021;13:3173. https://doi.org/10.3390/nu13093173.CrossRefPubMedPubMedCentral

11.

Arranz S, Chiva-Blanch G, Valderas-Martínez P, Medina-Remón A, Lamuela-Raventós RM, Estruch R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients. 2012;4:759–81. https://doi.org/10.3390/nu4070759.CrossRefPubMedPubMedCentral

12.

Golan R, Gepner Y, Shai I. Wine and health-new evidence. Eur J Clin Nutr. 2019;72:55–9. https://doi.org/10.1038/s41430-018-0309-5.CrossRefPubMed

13.

Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res. 2009;33:220–32. https://doi.org/10.1111/j.1530-0277.2008.00842.x.CrossRefPubMed

14.

Shivappa N, Jackson MD, Bennett F, Hébert JR. Increased Dietary Inflammatory Index (DII) is Associated with increased risk of prostate Cancer in jamaican men. Nutr Cancer. 2015;67:941–8. https://doi.org/10.1080/01635581.2015.1062117.CrossRefPubMedPubMedCentral

15.

Shivappa N, Miao Q, Walker M, Hébert JR, Aronson KJ. Association between a dietary inflammatory index and prostate Cancer risk in Ontario, Canada. Nutr Cancer. 2017;69:825–32. https://doi.org/10.1080/01635581.2017.1339095.CrossRefPubMedPubMedCentral

16.

Shivappa N, Hébert JR, Askari F, Kardoust Parizi M, Rashidkhani B. Increased inflammatory potential of Diet is Associated with increased risk of prostate Cancer in iranian men. Int J Vitam Nutr Res. 2016;86:161–8. https://doi.org/10.1024/0300-9831/a000395.CrossRefPubMed

17.

Shivappa N, Niclis C, Coquet JB, Román MD, Hébert JR, Diaz M. del P. increased inflammatory potential of diet is associated with increased odds of prostate cancer in argentinian men. Cancer Causes Control. 2018;29:803–13. https://doi.org/10.1007/s10552-018-1056-6.CrossRefPubMedPubMedCentral

18.

Hoang DV, Shivappa N, Pham NM, Hebert JR, Binns CW, Lee AH. Dietary inflammatory index is associated with increased risk for prostate cancer among vietnamese men. Nutrition. 2019;62:140–5. https://doi.org/10.1016/j.nut.2018.12.012.CrossRefPubMed

19.

Lozano-Lorca M, Salcedo-Bellido I, Olmedo-Requena R, Castaño-Vinyals G, Amiano P, Shivappa N, Hébert JR, Pérez-Gómez B, Gracia-Lavedan E, Gómez-Acebo I, et al. Dietary inflammatory index and prostate cancer risk: MCC-Spain study. Prostate Cancer Prostatic Dis. 2022;25:568–75. https://doi.org/10.1038/s41391-022-00532-7.CrossRefPubMed

20.

Shivappa N, Bosetti C, Zucchetto A, Montella M, Serraino D, La Vecchia C, Hébert JR. Association between dietary inflammatory index and prostate cancer among italian men. Br J Nutr. 2015;113:278–83. https://doi.org/10.1017/S0007114514003572.CrossRefPubMed

21.

Graffouillère L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hébert JR, Wirth MD, Latino-Martel P, Hercberg S, Galan P, et al. The Dietary Inflammatory Index is Associated with prostate Cancer risk in french middle-aged adults in a prospective study. J Nutr. 2015;146:785–91. https://doi.org/10.3945/jn.115.225623.CrossRef

22.

Zhu Y, Li Q, Xu X. Dietary inflammatory index and the risk of prostate cancer: a dose-response meta-analysis. Eur J Clin Nutr. 2020;74:1001–8. https://doi.org/10.1038/s41430-019-0500-3.CrossRefPubMed

23.

Vidal AC, Oyekunle T, Howard LE, Shivappa N, De Hoedt A, Figueiredo JC, Taioli E, Fowke JH, Lin P-H, Hebert JR, et al. Dietary inflammatory index (DII) and risk of prostate cancer in a case–control study among black and white US veteran men. Prostate Cancer Prostatic Dis. 2019;22:580–7. https://doi.org/10.1038/s41391-019-0143-4.CrossRefPubMedPubMedCentral

24.

Vázquez-Salas RA, Shivappa N, Galván-Portillo M, López-Carrillo L, Hébert JR, Torres-Sánchez L. Dietary inflammatory index and prostate cancer risk in a case–control study in Mexico. Br J Nutr. 2016;116:1945–53. https://doi.org/10.1017/S0007114516003986.CrossRefPubMed

25.

Abrahamsson P-A, Lilja H, Oesterling JE, MOLECULAR FORMS OF SERUM, PROSTATE-SPECIFIC, ANTIGEN. Urol Clin North Am. 1997;24:353–65. https://doi.org/10.1016/s0094-0143(05)70382-7.CrossRefPubMed

26.

Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 1995;274:1214–20.CrossRefPubMed

27.

Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer. Prostate. 2015;75:1167–76. https://doi.org/10.1002/pros.22998.CrossRefPubMedPubMedCentral

28.

NHANES 2009–2010. : Prostate Specific Antigen (PSA) Data Documentation, Codebook, and Frequencies. https://wwwn.cdc.gov/Nchs/Nhanes/2009-2010/PSA_F.htm [Accessed November 9, 2022].

29.

Ng TK, Vasilareas D, Mitterdorfer AJ, Maher PO, Lalak A. Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice. BJU Int. 2005;95:545–8. https://doi.org/10.1111/j.1464-410X.2005.05336.x.CrossRefPubMed

30.

Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol (1990) 143:1146–1152; discussion 1152–1154. doi: https://doi.org/10.1016/s0022-5347(17)40211-4.

31.

Qi Y, Zhang S, Wei J, Zhang G, Lei J, Yan W, Xiao Y, Yan S, Xue H, Feng F, et al. Multiparametric MRI-Based radiomics for prostate Cancer Screening with PSA in 4–10 ng/mL to reduce unnecessary biopsies. J Magn Reson Imaging. 2020;51:1890–9. https://doi.org/10.1002/jmri.27008.CrossRefPubMed

32.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112:2735–52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed

33.

Van’t Klooster CC, Ridker PM, Hjortnaes J, van der Graaf Y, Asselbergs FW, Westerink J, Aerts JGJV, Visseren FLJ. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40:3901–9. https://doi.org/10.1093/eurheartj/ehz587.CrossRefPubMedPubMedCentral

34.

De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB, Nelson WG. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem. 2004;91:459–77. https://doi.org/10.1002/jcb.10747.CrossRefPubMed

35.

Nelson WG, DeWeese TL, DeMarzo AM. The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev. 2002;21:3–16. https://doi.org/10.1023/a:1020110718701.CrossRefPubMed

36.

Mengus C, Le Magnen C, Trella E, Yousef K, Bubendorf L, Provenzano M, Bachmann A, Heberer M, Spagnoli GC, Wyler S. Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J Transl Med. 2011;9:162. https://doi.org/10.1186/1479-5876-9-162.CrossRefPubMedPubMedCentral

37.

Nakai Y, Nonomura N. Inflammation and prostate carcinogenesis. Int J Urol. 2013;20:150–60. https://doi.org/10.1111/j.1442-2042.2012.03101.x.CrossRefPubMed

38.

Cai T, Santi R, Tamanini I, Galli IC, Perletti G, Bjerklund Johansen TE, Nesi G. Current knowledge of the potential links between inflammation and prostate Cancer. IJMS. 2011;20:3833. https://doi.org/10.3390/ijms20153833.CrossRef

39.

Nelson WG, DeMarzo AM, Yegnasubramanian S. The Diet as a cause of human prostate Cancer. Cancer Treat Res. 2014;159:51–68. https://doi.org/10.1007/978-3-642-38007-5_4.CrossRefPubMedPubMedCentral

40.

Phillips CM, Chen L-W, Heude B, Bernard JY, Harvey NC, Duijts L, Mensink-Bout SM, Polanska K, Mancano G, Suderman M, et al. Dietary inflammatory index and non-communicable disease risk: a narrative review. Nutrients. 2019;11:1873. https://doi.org/10.3390/nu11081873.CrossRefPubMedPubMedCentral

41.

Accardi G, Shivappa N, Di Maso M, Hébert JR, Fratino L, Montella M, La Vecchia C, Caruso C, Serraino D, Libra M, et al. Dietary inflammatory index and cancer risk in the elderly: a pooled-analysis of italian case-control studies. Nutrition. 2019;63–4. https://doi.org/10.1016/j.nut.2019.02.008.

42.

McMahon DM, Burch JB, Hébert JR, Hardin JW, Zhang J, Wirth MD, Youngstedt SD, Shivappa N, Jacobsen SJ, Caan B, et al. Diet-related inflammation and risk of prostate cancer in the California Men’s Health Study. Ann Epidemiol. 2019;29:30–8. https://doi.org/10.1016/j.annepidem.2018.10.008.CrossRefPubMed

43.

Drazer MW. 2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates. JAMA (2012) 307:1692. doi: https://doi.org/10.1001/jama.2012.534.

44.

Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Screening for prostate Cancer: a Guidance Statement from the clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013;158:761. https://doi.org/10.7326/0003-4819-158-10-201305210-00633.CrossRefPubMed

Title: Interaction between drinking and dietary inflammatory index affects prostate specific antigen: a cross-sectional study
Authors: Xiangtao Weng
Wenyue Tan
Baian Wei
Shijian Yang
Chiming Gu
Shusheng Wang
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Prostate Cancer
Prostate Cancer
Nutrition
Published in: BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI: https://doi.org/10.1186/s12877-023-04151-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

The effect of volunteer-led activities on the quality of life of volunteers, residents, and employees of a long-term care institution: a cohort study

Trend of incidence rate of age-related diseases: results from the National Health Insurance Service–National Sample Cohort (NHIS-NSC) database in Korea: a cross- sectional study

Age-related differences in the occurrence, severity, and distress of symptoms in older patients at the initiation of chemotherapy

Effects of exercise and physical activity on gut microbiota composition and function in older adults: a systematic review

Restoring walking ability in older adults with arm-in-arm gait training: study protocol for the AAGaTT randomized controlled trial

Aesthetics of everyday life and its related factors among older adults in Kashan (2021–2022)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials